Rapid Readout: Angiopoietin-2 (Ang2) Inhibition in the Treatment of Diabetic Macular Edema and Exudative AMD.

EP. 1: Angiogenesis 2021 Virtual Symposium Takeaways & Final Thoughts

March 22nd 2021

Angiogenesis, Exudation, and Degeneration 2021 Virtual Symposium highlights and thoughts on current treatments options for DME and exudative AMD are discussed.

EP. 2: Ang-2/VEGF-A Inhibition Synergistic Effect in DME and AMD

ByAnat Loewenstein, MD

March 22nd 2021

Anat Loewenstein, MD, MHA, explores dual Ang-2/VEGF-A inhibition in the management of diabetic macular edema and exudative age-related macular degeneration.

Rapid Readout: Angiopoietin-2 (Ang2) Inhibition in the Treatment of Diabetic Macular Edema and Exudative AMD.

EP. 1: Angiogenesis 2021 Virtual Symposium Takeaways & Final Thoughts

EP. 2: Ang-2/VEGF-A Inhibition Synergistic Effect in DME and AMD

Trending on Ophthalmology Times Europe

Q&A: Arshad Khanani discussed the open-label extension of the GATHER2 trial

Q&A: Sharon Fekrat discusses retinal manifestations of antipsychotic medications